$GERN
GERON CORP

2018 Q2 Form 10-Q Financial Statement

#000156459018012931 Filed on May 10, 2018

View on sec.gov

Income Statement

Concept 2018 Q2 2018 Q1 2017 Q1
Revenue $208.0K $318.0K $537.0K
YoY Change 19.54% -40.78% -28.3%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.250M $5.320M $4.660M
YoY Change -3.63% 14.16% -2.71%
% of Gross Profit
Research & Development $3.204M $2.440M $3.374M
YoY Change 28.16% -27.68% -32.92%
% of Gross Profit
Depreciation & Amortization $10.00K $16.00K $20.00K
YoY Change -50.0% -20.0% 0.0%
% of Gross Profit
Operating Expenses $7.450M $7.755M $8.031M
YoY Change 7.89% -3.44% -18.27%
Operating Profit -$7.242M -$7.437M -$7.494M
YoY Change -0.76%
Interest Expense $330.0K $250.0K $310.0K
YoY Change 0.0% -19.35% 29.17%
% of Operating Profit
Other Income/Expense, Net -$20.00K
YoY Change
Pretax Income -$6.930M -$7.190M -$7.180M
YoY Change 8.11% 0.14% -18.78%
Income Tax
% Of Pretax Income
Net Earnings -$6.934M -$7.186M -$7.183M
YoY Change 8.26% 0.04% -18.76%
Net Earnings / Revenue -3333.65% -2259.75% -1337.62%
Basic Earnings Per Share
Diluted Earnings Per Share -$39.72K -$44.79K -$45.11K
COMMON SHARES
Basic Shares Outstanding 173.1M 160.7M
Diluted Shares Outstanding

Balance Sheet

Concept 2018 Q2 2018 Q1 2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $160.9M $89.80M $99.30M
YoY Change 69.73% -9.57% -9.4%
Cash & Equivalents $19.40M $7.912M $15.13M
Short-Term Investments $141.8M $81.90M $84.40M
Other Short-Term Assets $600.0K $800.0K $6.700M
YoY Change -91.18% -88.06% 857.14%
Inventory
Prepaid Expenses $512.0K
Receivables
Other Receivables
Total Short-Term Assets $162.3M $91.13M $106.6M
YoY Change 58.96% -14.51% -3.96%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $86.00K $200.0K
YoY Change 0.0% -57.0% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $20.30M $13.20M $22.10M
YoY Change -8.14% -40.27% -30.94%
Other Assets $700.0K $1.189M
YoY Change
Total Long-Term Assets $21.00M $14.38M $22.20M
YoY Change -5.41% -35.21% -30.84%
TOTAL ASSETS
Total Short-Term Assets $162.3M $91.13M $106.6M
Total Long-Term Assets $21.00M $14.38M $22.20M
Total Assets $183.3M $105.5M $128.8M
YoY Change 47.47% -18.08% -9.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $500.0K $502.0K $300.0K
YoY Change 150.0% 67.33% -25.0%
Accrued Expenses $4.400M $3.900M $5.000M
YoY Change -8.33% -22.0% -20.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.900M $4.385M $11.60M
YoY Change -56.64% -62.2% 73.13%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.900M $4.385M $11.60M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $4.900M $4.400M $11.60M
YoY Change -56.64% -62.07% 73.13%
SHAREHOLDERS EQUITY
Retained Earnings -$984.4M
YoY Change
Common Stock $1.093B
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $178.4M $101.1M $117.3M
YoY Change
Total Liabilities & Shareholders Equity $183.3M $105.5M $128.8M
YoY Change 47.47% -18.08% -9.99%

Cashflow Statement

Concept 2018 Q2 2018 Q1 2017 Q1
OPERATING ACTIVITIES
Net Income -$6.934M -$7.186M -$7.183M
YoY Change 8.26% 0.04% -18.76%
Depreciation, Depletion And Amortization $10.00K $16.00K $20.00K
YoY Change -50.0% -20.0% 0.0%
Cash From Operating Activities -$4.490M -$7.368M -$7.307M
YoY Change 1.13% 0.83% 30.95%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$66.61M -$2.610M $9.360M
YoY Change 1625.65% -127.88% -355.04%
Cash From Investing Activities -$66.61M -$2.608M $9.358M
YoY Change 1625.65% -127.87% -353.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.553M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 82.32M 1.553M 0.000
YoY Change 205700.0% -100.0%
NET CHANGE
Cash From Operating Activities -4.490M -7.368M -7.307M
Cash From Investing Activities -66.61M -2.608M 9.358M
Cash From Financing Activities 82.32M 1.553M 0.000
Net Change In Cash 11.22M -8.423M 2.051M
YoY Change -235.84% -510.68% -124.3%
FREE CASH FLOW
Cash From Operating Activities -$4.490M -$7.368M -$7.307M
Capital Expenditures $0.00
Free Cash Flow -$7.307M
YoY Change 31.66%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2018Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2017Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
78351000
CY2018Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
569000
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1089684000
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
580000
CY2018Q1 us-gaap Assets Current
AssetsCurrent
91129000
CY2017Q4 us-gaap Assets Current
AssetsCurrent
95970000
CY2018Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2018Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16335000
CY2018Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
268000
CY2017Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
268000
CY2018Q1 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
81868000
CY2018Q1 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
13184000
CY2017Q4 us-gaap Available For Sale Securities Noncurrent
AvailableForSaleSecuritiesNoncurrent
14241000
CY2018Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86000
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
102000
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1114000
CY2017Q4 us-gaap Assets
Assets
110313000
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
503000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3385000
CY2017Q4 gern Collaborative Arrangement Accrued Collaboration Charges Current
CollaborativeArrangementAccruedCollaborationChargesCurrent
1702000
CY2018Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
CY2018Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7912000
CY2018Q1 us-gaap Common Stock Value
CommonStockValue
161000
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
160000
CY2017Q4 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
436000
CY2018Q1 us-gaap Assets
Assets
105513000
CY2018Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
502000
CY2018Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1100000
CY2018Q1 gern Collaborative Arrangement Accrued Collaboration Charges Current
CollaborativeArrangementAccruedCollaborationChargesCurrent
1841000
CY2018Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
942000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
926000
CY2018Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4385000
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6516000
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1092931000
CY2018Q1 dei Trading Symbol
TradingSymbol
GERN
CY2018Q1 us-gaap Depreciation
Depreciation
16000
CY2017Q1 us-gaap Depreciation
Depreciation
20000
CY2017Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-5000
CY2018Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-24000
CY2017Q1 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-55000
CY2018Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
71000
CY2017Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
57000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1614000
CY2018Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
173080653
CY2018Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
512000
CY2018Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
2440000
CY2018Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5315000
CY2017Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4657000
CY2018Q1 us-gaap Operating Expenses
OperatingExpenses
7755000
CY2017Q1 us-gaap Operating Expenses
OperatingExpenses
8031000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7437000
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7494000
CY2018Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
394000
CY2017Q1 us-gaap Interest And Other Income
InterestAndOtherIncome
332000
CY2018Q1 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
125000
CY2018Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
18000
CY2017Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
21000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-7186000
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-7183000
CY2018Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2017Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2018Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
160525947
CY2017Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
159161550
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-124000
CY2017Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-18000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7310000
CY2017Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7201000
CY2017Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1983000
CY2018Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
10000
CY2017Q1 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
32000
CY2018Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-89000
CY2017Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6003000
CY2018Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-2131000
CY2017Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
3727000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7368000
CY2017Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7307000
CY2018Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
19768000
CY2017Q1 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
28282000
CY2018Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
17160000
CY2017Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
37640000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2608000
CY2017Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
9358000
CY2018Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1553000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1553000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8423000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2051000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16603000
CY2016Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13078000
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
110313000
CY2017Q1 gern Licenses And Royalty Revenue
LicensesAndRoyaltyRevenue
537000
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-985840000
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-207000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
103797000
CY2018Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
105513000
CY2018Q1 gern Licenses And Royalty Revenue
LicensesAndRoyaltyRevenue
318000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-991633000
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-331000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
101128000
CY2017Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
3374000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8180000
CY2018Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1
204000
CY2017Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15129000
CY2018Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Prior Period Reclassification</p> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:5%;">With the adoption of Accounting Standards Update, or ASU, No. 2016-18, <font style="font-style:italic;">Statement of Cash Flows (Topic 230) Restricted Cash</font>, or ASU No. 2016-18, the prior period presentation of cash and cash equivalents in the condensed statements of cash flows has been updated to conform with current period presentation. See &#8220;New Accounting Pronouncements &#8211; Recently Adopted&#8221; in this Note 1 on Summary of Significant Accounting Policies for further discussion of the adoption of ASU No. 2016-18.</p></div>
CY2018Q1 us-gaap Nontrade Receivables Current
NontradeReceivablesCurrent
640000
CY2018Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1189000
CY2018Q1 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles, or GAAP. The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an ongoing basis, we evaluate our estimates, including those related to accrued liabilities, revenue recognition, fair value of marketable securities and equity investments, income taxes, and stock-based compensation. We base our estimates on historical experience and on various other market specific and relevant assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.</p></div>
CY2018Q1 us-gaap Property Plant And Equipment Useful Life
PropertyPlantAndEquipmentUsefulLife
P4Y
CY2018Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1614000
CY2017Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1983000
CY2017Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
15021000
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
92592000
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
75089000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
77168000
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
290000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
169000
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
16497000
CY2018Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-984447000
CY2018Q1 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
95383000
CY2018Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2018Q1 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
338000
CY2018Q1 us-gaap Available For Sale Securities
AvailableForSaleSecurities
95052000
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
15022000
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
92798000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2017Q4 gern Cash And Cash Equivalents Unrealized Losses
CashAndCashEquivalentsUnrealizedLosses
1000
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
210000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
13959000
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
48000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
42000
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
91586000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue
91127000
CY2018Q1 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
338000
CY2017Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss
211000
CY2015Q3 gern Common Stock Aggregate Offering Price
CommonStockAggregateOfferingPrice
50000000
CY2015Q3 gern Maximum Commission Rate
MaximumCommissionRate
0.030
CY2018Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
776788
CY2018Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1553000

Files In Submission

Name View Source Status
0001564590-18-012931-index-headers.html Edgar Link pending
0001564590-18-012931-index.html Edgar Link pending
0001564590-18-012931.txt Edgar Link pending
0001564590-18-012931-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gern-10q_20180331.htm Edgar Link pending
gern-20180331.xml Edgar Link completed
gern-20180331.xsd Edgar Link pending
gern-20180331_cal.xml Edgar Link unprocessable
gern-20180331_def.xml Edgar Link unprocessable
gern-20180331_lab.xml Edgar Link unprocessable
gern-20180331_pre.xml Edgar Link unprocessable
gern-ex311_8.htm Edgar Link pending
gern-ex312_9.htm Edgar Link pending
gern-ex321_6.htm Edgar Link pending
gern-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending